Cargando…
Targeted Therapy in Biliary Tract Cancers
A paradigm shift towards molecular-based, personalized cancer therapeutics has occurred in recent years and a number of targeted drugs have emerged. Various targeted therapies like erlotinib, trastuzumab, and cetuximab have been approved in lung, breast, and colon cancers, respectively. Numerous cli...
Autores principales: | Merla, Amartej, Liu, Kenneth G., Rajdev, Lakshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534500/ https://www.ncbi.nlm.nih.gov/pubmed/26266637 http://dx.doi.org/10.1007/s11864-015-0366-0 |
Ejemplares similares
-
Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
por: Chan, Jennifer, et al.
Publicado: (2014) -
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023) -
Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021) -
Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi‐institutional propensity score‐matched study
por: Bracale, Umberto, et al.
Publicado: (2021) -
Detection of sarcopenic obesity and prediction of long‐term survival in patients with gastric cancer using preoperative computed tomography and machine learning
por: Kim, Jaehyuk, et al.
Publicado: (2021)